XL765 (SAR245409)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for XL765 (SAR245409), covering 2013-04-10 to 2013-04-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas [Phase 1]